ArticleFrontiers in pharmacology2024
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation.
Yang-Qi Pan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it